PL3352766T3 - Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia - Google Patents

Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia

Info

Publication number
PL3352766T3
PL3352766T3 PL16778947T PL16778947T PL3352766T3 PL 3352766 T3 PL3352766 T3 PL 3352766T3 PL 16778947 T PL16778947 T PL 16778947T PL 16778947 T PL16778947 T PL 16778947T PL 3352766 T3 PL3352766 T3 PL 3352766T3
Authority
PL
Poland
Prior art keywords
hyaluronane
compositions
application
high flexibility
flexibility
Prior art date
Application number
PL16778947T
Other languages
English (en)
Inventor
Carlos Belmonte
Janet L. Denlinger
Original Assignee
Matrix Biology Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Biology Institute filed Critical Matrix Biology Institute
Publication of PL3352766T3 publication Critical patent/PL3352766T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
PL16778947T 2015-09-24 2016-09-21 Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia PL3352766T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562232364P 2015-09-24 2015-09-24
EP16778947.8A EP3352766B1 (en) 2015-09-24 2016-09-21 High elasticity hyaluronan compositions and methods of use thereof
PCT/US2016/052743 WO2017053339A1 (en) 2015-09-24 2016-09-21 High elasticity hyaluronan compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
PL3352766T3 true PL3352766T3 (pl) 2021-08-02

Family

ID=57121519

Family Applications (2)

Application Number Title Priority Date Filing Date
PL16778947T PL3352766T3 (pl) 2015-09-24 2016-09-21 Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia
PL21156772.2T PL3842047T3 (pl) 2015-09-24 2016-09-21 Kompozycje hialuronanu o wysokiej elastyczności i sposoby ich zastosowania

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL21156772.2T PL3842047T3 (pl) 2015-09-24 2016-09-21 Kompozycje hialuronanu o wysokiej elastyczności i sposoby ich zastosowania

Country Status (11)

Country Link
US (4) US10383889B2 (pl)
EP (3) EP3842047B1 (pl)
JP (4) JP6948716B2 (pl)
CN (2) CN108135926A (pl)
ES (2) ES2990076T3 (pl)
HU (2) HUE068774T2 (pl)
PL (2) PL3352766T3 (pl)
PT (2) PT3352766T (pl)
RU (2) RU2727809C2 (pl)
WO (1) WO2017053339A1 (pl)
ZA (1) ZA202007149B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180042978A1 (en) * 2008-04-10 2018-02-15 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of treating photo-induced ocular fatigue and associated reduction in speed of ocular focus
PT3613423T (pt) 2013-07-10 2022-12-07 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
PT3352766T (pt) 2015-09-24 2022-03-22 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e processos para o seu uso
EP3713617A1 (en) 2017-11-22 2020-09-30 Bausch & Lomb Incorporated Ophthalmic viscoelastic compositions
US12303527B2 (en) 2018-04-18 2025-05-20 i.com medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
BR112021000724A2 (pt) 2018-07-27 2021-04-13 Johnson & Johnson Surgical Vision, Inc. Composições e métodos para tratar os olhos
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US12268706B2 (en) 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
ES2837548B2 (es) * 2019-12-31 2022-04-18 Univ Miguel Hernandez De Elche Umh Procedimiento y dispositivo para producir una secreción lagrimal refleja y un kit para la medición de la magnitud de flujo lagrimal generado
CN111617313B (zh) * 2020-04-29 2022-09-06 天津医科大学眼科医院 一种眼用线性凝胶在作为临床孔源性视网膜脱离药物方面中的应用
JP2023530286A (ja) * 2020-06-12 2023-07-14 アイ．コム メディカル ゲーエムベーハー 角膜神経損傷又は喪失の治療に使用する高分子量ヒアルロン酸
IT202000025264A1 (it) 2020-10-26 2022-04-26 Innate S R L Composizione iniettabile comprendente acido ialuronico e uso della detta composizione.
US11951123B2 (en) 2022-01-12 2024-04-09 Platform Ophthalmic Innovations, LLC Fortified nutritional lubricating drops for dry eye disease
US12397017B2 (en) 2022-01-12 2025-08-26 Platform Ophthalmic Innovations, LLC Fortified nutritional lubricating drops for dry eye disease

Family Cites Families (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4517295A (en) 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
CH666897A5 (fr) 1983-10-11 1988-08-31 Fidia Spa Fractions d'acide hyaluronique non inflammatoire, procedes et compositions pharmaceutiques.
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5403592A (en) 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
AU620821B2 (en) 1987-08-25 1992-02-27 Macnaught Pty Limited Hyaluronic acid lubricating compounds
EP0414373B2 (en) 1989-07-24 2001-04-25 Allergan Pharmaceuticals (Ireland) Limited Stable solution of hyaluronate in a balanced salt medium
AU652022B2 (en) 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US5234914A (en) 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
AU682670B2 (en) 1993-02-05 1997-10-16 Becton Dickinson & Company Syringe needle isolation device
US5583120A (en) 1993-08-04 1996-12-10 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5607400A (en) 1995-05-19 1997-03-04 Becton, Dickinson And Company Pre-fillable syringe and stopper assembly therefor
IT1277707B1 (it) 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
JPH09173450A (ja) 1995-12-26 1997-07-08 Nissho Corp プレフィルドシリンジ
JP3293122B2 (ja) 1996-12-13 2002-06-17 ニプロ株式会社 プレフィルドシリンジ
SE9700827D0 (sv) * 1997-03-07 1997-03-07 Pharmacia & Upjohn Ab Ophthalmic composition
RU2126669C1 (ru) 1997-04-25 1999-02-27 Новокузнецкий государственный институт усовершенствования врачей Способ лечения синдрома сухого глаза
SE9703425D0 (sv) 1997-09-23 1997-09-23 Pharmacia & Upjohn Ab Prefilled ampooules and manufacture thereof
DE19751219A1 (de) 1997-11-19 1999-05-27 Vetter & Co Apotheker Spritze, insbesondere vorgefüllte Spritze, oder Karpule
US6164044A (en) 1998-03-13 2000-12-26 Becton Dickinson And Company Method and apparatus for assembling and packaging medical devices
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
JP3591636B2 (ja) 2000-04-03 2004-11-24 ニプロ株式会社 プレフィルドシリンジ
PT1142566E (pt) 2000-04-07 2004-02-27 Medidom Lab Formulacao oftalmica topica na forma de uma solucao aquosa e uso de uma ciclosporina em associacao com acido hialuronico ou um de seus sais e com polisorbato 80
US7635489B2 (en) * 2001-05-18 2009-12-22 Leneau Holdings, Llc Ingestion of hyaluronic acid for improved joint health
JP2003119147A (ja) 2001-10-10 2003-04-23 Raku:Kk ヒアルロン酸化合物の水溶液組成物
WO2003043660A2 (en) * 2001-11-21 2003-05-30 Novartis Ag Composition for stabilizing hyaluronic acid
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
JP4141156B2 (ja) 2002-03-15 2008-08-27 日本ベクトン・ディッキンソン株式会社 プランジャ後退制限機構付きプレフィルドシリンジ
WO2004004811A1 (ja) 2002-07-02 2004-01-15 Terumo Kabushiki Kaisha シリンジおよびプレフィルドシリンジ
US20060094643A1 (en) 2002-07-03 2006-05-04 Yuri Svirkin Compositions of hyaluronic acid and methods of use
US7795203B2 (en) 2002-09-30 2010-09-14 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
DE10254321A1 (de) 2002-11-21 2004-06-17 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Vorgefüllte Spritze
WO2004058289A1 (en) * 2002-12-20 2004-07-15 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
JP2004229750A (ja) 2003-01-28 2004-08-19 Nipro Corp プレフィルドシリンジ及びそのバレルの製造方法
US20040167480A1 (en) 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
JP2004262777A (ja) 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
AR044302A1 (es) 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
US20050059639A1 (en) 2003-09-11 2005-03-17 Wei Edward T. Ophthalmic compositions and method for treating eye discomfort and pain
US20050075611A1 (en) 2003-10-01 2005-04-07 Hetzler Kevin G. Low extractable, thermoplastic syringe and tip cap
US20090148527A1 (en) 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
AU2005244059A1 (en) 2004-05-07 2005-11-24 S.K. Pharmaceuticals, Inc. Stabilized hyaluronan preparations and related methods
US8372814B2 (en) 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
CN103860582A (zh) 2004-12-30 2014-06-18 建新公司 用于关节内粘弹性补充的方案
US8388995B1 (en) 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
ITPD20050056A1 (it) 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
US7767710B2 (en) 2005-05-25 2010-08-03 Calosyn Pharma, Inc. Method for treating osteoarthritis
DE102005055275A1 (de) * 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
US8039447B2 (en) 2005-11-22 2011-10-18 Centre National De La Recherche Scientifique (C.N.R.S.) Derivatives of hyaluronic acid, their preparation process and their uses
US7988675B2 (en) 2005-12-08 2011-08-02 West Pharmaceutical Services Of Delaware, Inc. Automatic injection and retraction devices for use with pre-filled syringe cartridges
WO2007070547A2 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
JP4682850B2 (ja) 2006-01-12 2011-05-11 ニプロ株式会社 プレフィルドシリンジ
US20070254841A1 (en) 2006-01-25 2007-11-01 Ophthalmic Research Associates, Inc. Formulations and methods for treating dry eye
US7674781B2 (en) 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
WO2008011836A2 (es) 2006-07-25 2008-01-31 Osmotica Corp. Soluciones oftálmicas
EP2059206B8 (en) * 2006-08-28 2012-07-11 Rexaderm, Inc. Dry wound dressing and drug delivery system
ITMI20061668A1 (it) 2006-09-01 2008-03-02 Schiena Michele Giuseppe Di Composizione a base di acido ialuronico e suoi sali per il trattamento di lesioni epiteliali
EP2087020A4 (en) 2006-11-17 2010-11-24 Agency Science Tech & Res POROUS POLYMERIC MATERIAL WITH NETWORKABLE NETWORK
EP1994934A4 (en) 2006-12-05 2010-03-10 Glycoscience Lab Inc THERAPEUTIC AGENT AGAINST DEGENERATIVE ARTHRITIS
FR2918276B1 (fr) 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
JP2009196903A (ja) 2008-02-19 2009-09-03 Lion Corp 眼科用組成物
WO2009111159A2 (en) 2008-03-03 2009-09-11 New York University Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
JP5758797B2 (ja) 2008-04-04 2015-08-05 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション アルキル化半合成グリコサミノグリカンエーテルならびにその製造および使用方法
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
CA2749034C (en) 2009-01-07 2019-01-15 Robert John Petrella Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
US20100178317A1 (en) 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
US8979821B2 (en) 2009-04-14 2015-03-17 Fezza Family Properties, Llc Lacrimal filler
US20100303915A1 (en) 2009-06-02 2010-12-02 Abbott Medical Optics Inc. Therapeutic opthalmic emulsions
US20120128754A1 (en) 2009-06-05 2012-05-24 Edward Tak Wei Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid
US20110071630A1 (en) 2009-09-10 2011-03-24 Boston Foundation For Sight Sodium channel blocker delivery system with scleral lens
EP2485754A1 (en) 2009-10-07 2012-08-15 Genogen, Inc. Methods and compositions for skin regeneration
EP2316420B1 (en) * 2009-10-22 2014-02-26 Consorzio Universitario Unifarm Topical ophthalmic composition to reduce pain
US20110171310A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
EP4062950A1 (en) * 2010-03-22 2022-09-28 Allergan, Inc. Syringe comprising dermal filler for soft tissue augmentation
US20130209531A1 (en) 2010-06-08 2013-08-15 University Of Utah Research Foundation Applications of partially and fully sulfated hyaluronan
WO2012027834A1 (en) 2010-09-02 2012-03-08 Mcmaster University Hyaluronic acid-containing biopolymers
CA2810481C (en) 2010-09-10 2018-06-19 Santen Pharmaceutical Co., Ltd. Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
JP6047272B2 (ja) 2010-09-15 2016-12-21 テイカ製薬株式会社 角膜上皮障害治療用点眼剤
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
EP2694048B1 (en) * 2011-04-05 2020-10-07 Optosolve Research & Development Ltd Ophthalmic treatments
WO2012143876A1 (en) 2011-04-19 2012-10-26 Anteis S.A. A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
GB201118586D0 (en) 2011-10-27 2011-12-07 Turzi Antoine New A-PRP medical device, manufacturing machine and process
DK2596796T3 (da) * 2011-11-24 2014-01-27 Quimera Ingenieria Biomedica S L Kompleks opnået af hyaluronsyre eller et salt deraf samt chondroitinsulfatblandinger
HK1205461A1 (zh) 2012-02-22 2015-12-18 Trustees Of Tufts College 用於眼部传输治疗剂的组合物和方法
WO2013125634A1 (ja) 2012-02-22 2013-08-29 株式会社ヒアルロン酸研究所 ヒアルロン酸フラグメントを有効成分とするサーチュイン誘導剤、組織修復剤、肝細胞増殖因子誘導剤、組織恒常性維持剤、及びｔｌｒ４作用剤
UA113434C2 (uk) 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
FR2991876B1 (fr) * 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2994846B1 (fr) * 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
DK2950783T3 (da) 2013-02-01 2019-07-22 Allergan Inc Kunstige tårer omfattende natriumhyaluronat og carboxymethylcellulose
US9226938B2 (en) 2013-03-14 2016-01-05 RMG Rehabilitation Management Group, LP Combinatorial therapy for treatment of osteoarthritis of the knee
EP2979539B1 (en) * 2013-03-25 2017-12-20 National University Corporation Tokyo University Of Agriculture and Technology Plant cultivation method
ITMI20130883A1 (it) * 2013-05-30 2014-12-01 Eurores S R L Composizioni farmaceutiche comprendenti collagene e sodio ialuronato
PT3613423T (pt) * 2013-07-10 2022-12-07 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
WO2015074137A1 (en) 2013-11-20 2015-05-28 Mary Lynch Compositions and methods for treatment of ocular inflammation and pain
WO2015077736A1 (en) 2013-11-25 2015-05-28 Deuteria Biomaterials, Llc Deuterium-enriched hyaluronan
FR3015290B1 (fr) 2013-12-23 2017-01-13 Lab Vivacy Compositions d'acide hyaluronique compreant de la mepivacaine
PT3352766T (pt) 2015-09-24 2022-03-22 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e processos para o seu uso

Also Published As

Publication number Publication date
JP6948716B2 (ja) 2021-10-13
RU2018114926A (ru) 2019-10-24
EP4474011A3 (en) 2025-02-26
ZA202007149B (en) 2025-04-30
JP2023153417A (ja) 2023-10-17
EP3842047A1 (en) 2021-06-30
US11583549B2 (en) 2023-02-21
JP2018529691A (ja) 2018-10-11
US20170087177A1 (en) 2017-03-30
CN108135926A (zh) 2018-06-08
ES2990076T3 (es) 2024-11-28
EP4474011A2 (en) 2024-12-11
PT3352766T (pt) 2022-03-22
US10888580B2 (en) 2021-01-12
HUE054874T2 (hu) 2021-10-28
US20250381215A1 (en) 2025-12-18
US20210085709A1 (en) 2021-03-25
WO2017053339A1 (en) 2017-03-30
PL3842047T3 (pl) 2024-10-28
PT3842047T (pt) 2024-09-19
EP3352766B1 (en) 2021-03-17
US10383889B2 (en) 2019-08-20
EP3352766A1 (en) 2018-08-01
CN113577097A (zh) 2021-11-02
RU2018114926A3 (pl) 2019-10-24
EP3842047B1 (en) 2024-08-07
US20200030364A1 (en) 2020-01-30
JP2021165311A (ja) 2021-10-14
RU2020123728A (ru) 2021-01-18
HK1250657A1 (zh) 2019-01-11
HUE068774T2 (hu) 2025-01-28
RU2727809C2 (ru) 2020-07-24
JP2026004503A (ja) 2026-01-14
ES2871199T3 (es) 2021-10-28

Similar Documents

Publication Publication Date Title
PL3328199T3 (pl) Kompozycje przeciwdrobnoustrojowe i ich zastosowania
EP3722358A4 (en) COMPOSITION
PL3265448T3 (pl) Proleki riluzolu i ich zastosowanie
PL3407888T3 (pl) Związki pirydopirolochinoksaliny, ich kompozycje i zastosowania
DK3697376T3 (da) Sammensætning
PT3355990T (pt) Compostos semifluorados e as suas composições
PL3373755T3 (pl) Część do e-palenia i urządzenie do e-palenia oraz sposób ich wytwarzania
PL3443009T3 (pl) Przeciwciała i kompozycje anty-tim-3
PL3268470T3 (pl) Polipeptydy transpozazy i ich zastosowania
KR20180084891A (ko) 구조 조성물 및 방법
PL3258951T3 (pl) Przeciwciała anty-pvrig i sposoby ich zastosowania
PL3280441T3 (pl) Przeciwciała przeciwko sortilinie i sposoby ich stosowania
PL3259253T3 (pl) Pochodne sulfonylomocznika i związki pokrewne oraz ich zastosowanie
PL3386534T3 (pl) Kompozycje i sposoby internalizacji enzymów
PL3319612T3 (pl) Oksysterole i sposoby ich stosowania
DK3250182T3 (da) Dispergible sammensætninger
PL3393485T3 (pl) Kompozycje probiotyczne i ich zastosowanie
DK3334726T3 (da) Plinabulinsammensætninger
PT3261437T (pt) Compostos e composições fungicidas
PL3337506T3 (pl) Kombinacje i ich zastosowania
LT3651736T (lt) Ilgai veikiančios kompozicijos
DK3331498T3 (da) Nasalsammensætning
DK4234656T3 (da) Sammensætninger
EP3395887C0 (en) FLUOROR RUBBER COMPOSITION
DK3322295T3 (da) Sammensætning